Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+ Industry Domains
Report
Press Release
Blogs
Industry Statistics
Add 2 More Reports For 20% off

Report Overview

Metabolic syndrome is a cluster of metabolic abnormalities that increases the risk of cardiovascular disease and other chronic conditions. According to Zahra Jamali et al., epidemiological studies have reported a global prevalence of approximately 5–7% among young people. According to the metabolic syndrome epidemiology forecast by Expert Market Research, the prevalence of metabolic syndrome remains an important epidemiological indicator.

2025

Base Year

2019-2025

Historical Period

2026-2035

Forecast Period

Metabolic Syndrome – Number of Cases by Year

Read more about this report - Request a Free Sample

Metabolic Syndrome Epidemiology Forecast Report Coverage

Expert Market Research's “Metabolic Syndrome Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of metabolic syndrome. It projects the future incidence and prevalence rates of metabolic syndrome cases across various populations. The study covers age, gender, and type as major determinants of the metabolic syndrome population. The report highlights patterns in the prevalence of metabolic syndrome over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of metabolic syndrome in the 8 major markets.

Regions Covered

  • United States
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Japan
  • India

Metabolic Syndrome Understanding: Disease Overview

Metabolic syndrome is a cluster of interrelated metabolic abnormalities that collectively increase the risk of cardiovascular disease, type 2 diabetes, and other complications. It generally involves abdominal obesity, elevated blood pressure, elevated blood glucose, high triglyceride levels, and reduced high-density lipoprotein cholesterol. The condition develops through interacting factors such as insulin resistance, excess visceral fat, physical inactivity, genetic susceptibility, and unhealthy dietary patterns. Metabolic syndrome is not classified into distinct clinical types; rather, patients may present with different combinations and severity of its components. Insulin resistance is a central underlying mechanism.

Key Report Insights

Parameter

Insight

Largest Patient Pool

United States

Fastest Growing Country

India

High-Risk Population

Individuals with obesity, older adults, and people with sedentary lifestyles

Key Diagnostic Method

Assessment of metabolic syndrome components, including waist circumference, blood pressure, blood glucose, triglycerides, and high-density lipoprotein cholesterol

Major Risk Factor

Abdominal obesity and insulin resistance

Major gap in the market

Underdiagnosis and inconsistent identification of individuals with multiple metabolic risk factors

Metabolic Syndrome Epidemiology Perspective

The metabolic syndrome epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for the metabolic syndrome epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for metabolic syndrome and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

Epidemiology Segment

Key Insights

Diagnosed Prevalent Cases of the Disease

According to Jean Jacques Noubiap et al. (2025), global MetS prevalence increased from 14.7% among women and 9.0% among men in 2000 to 31.0% and 25.7%, respectively, in 2023. An estimated 1.54 billion adults had MetS in 2023.

Gender-Specific Cases of the Disease

As per Jean Jacques Noubiap et al. (2025), 846 million women and 692 million men were estimated to have MetS globally in 2023. Prevalence was higher among women than men in 102 countries, although the magnitude of sex differences varied substantially across countries.

Age-Specific Cases of the Disease

According to Jean Jacques Noubiap et al. (2025), MetS prevalence increased with age globally. P Swarna Latha et al. (2024) reported a prevalence of 39.8% in a study population with a mean age of 44.97 years, with age above 40 independently associated with MetS.

Ethnicity-Wise Cases of the Disease

According to Nia Heard-Garris et al. (2024), approximately one in three people in the United States has MetS, with racially and ethnically minoritized groups reported to have the highest prevalences. The available data indicate substantial variation in MetS burden across population groups.

Mortality and Survival Analysis of the Disease

According to Zahra Jamali et al., MetS in young people is relevant to future cardiovascular disease and associated mortality. Global prevalence reached 31.0% among women and 25.7% among men in 2023, indicating a substantial and increasing population-level burden.

Metabolic Syndrome – Number of Cases by Country

Read more about this report - Request a Free Sample

Country-wise Metabolic Syndrome Epidemiology

The metabolic syndrome epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

Country

Key Insights

United States

According to Nia Heard-Garris et al. (2024), approximately one in three people in the United States has metabolic syndrome. The epidemiological burden is associated with obesity, physical inactivity, and differences across racial and ethnic population groups.

Germany

According to the Bundesministerium für Gesundheit, 25% of adults in Germany are severely overweight and therefore at risk of developing metabolic syndrome. European epidemiological data also indicate variation in metabolic syndrome component patterns across German populations.

France

According to Jean Jacques Noubiap et al. (2025), France demonstrated a higher metabolic syndrome prevalence among men than women, with the absolute sex difference reaching −36.7%. Differences in age, obesity, metabolic risk factors, and population characteristics contribute to epidemiological variation.

Italy

According to Jean Jacques Noubiap et al. (2025), metabolic syndrome prevalence has increased across countries globally. European data indicate distinct metabolic syndrome component patterns in Italy, with the glucose–blood pressure–body-weight cluster accounting for 31.4% in Southern European cohorts.

Spain

According to Leila Lujan-Barroso et al. (2023), metabolic syndrome prevalence in Spain was approximately 40% among older men and 32% among older women. The epidemiological burden is associated with increasing obesity, insulin resistance, and type 2 diabetes prevalence.

United Kingdom

According to Jean Jacques Noubiap et al. (2025), metabolic syndrome prevalence has increased globally, with prevalence influenced by age, urbanization, and income. In the United Kingdom, population-level burden is also supported by high levels of obesity and related metabolic risk factors.

Japan

The epidemiological burden of metabolic syndrome in Japan is influenced by age-related metabolic risk, obesity, glucose abnormalities, blood pressure, and lipid disturbances. Population aging and changes in metabolic risk profiles are relevant factors shaping the country's epidemiological pattern.

India

According to P Swarna Latha et al. (2024), metabolic syndrome prevalence was 39.8% in the study population. Being older than 40 years, physical inactivity, and obesity were independently associated with metabolic syndrome, indicating important age and lifestyle-related epidemiological factors.

Key Market Gaps, Untapped Opportunities, and Emerging Growth Areas in the Regional Disease Epidemiology Landscape

A major gap in the metabolic syndrome epidemiology landscape is the inconsistent identification of individuals who have multiple cardiometabolic risk factors but have not yet developed overt diabetes or cardiovascular disease. Opportunities exist to strengthen routine screening for abdominal obesity, hypertension, dyslipidemia, and impaired glucose regulation, particularly among high-risk populations. India represents an important emerging growth area because changing dietary patterns, urbanization, physical inactivity, and increasing obesity can contribute to cardiometabolic risk. Across the United States, European countries, Japan, and India, integrated prevention strategies and earlier risk identification could support improved disease management and reduce progression to associated chronic conditions.

Metabolic Syndrome: Treatment Overview

Treatment for metabolic syndrome focuses on reducing the individual risk factors and preventing progression to cardiovascular disease and type 2 diabetes. Lifestyle modification is the foundation of management and includes weight reduction, regular physical activity, a balanced diet, smoking cessation, and moderation of alcohol intake. Depending on the patient's risk profile, medications may be used to control hypertension, hyperglycemia, dyslipidemia, or obesity. Management is generally individualized according to the predominant abnormalities and overall cardiovascular risk. Lifestyle intervention remains an important component of long-term disease management.

Key Questions Answered

  • What is the current and projected burden of metabolic syndrome across the 8 major markets?
  • Which countries across the 8 major markets account for the highest metabolic syndrome patient populations and fastest growth rates?
  • What is the diagnosed versus undiagnosed patient population of metabolic syndrome across key countries in the 8 major markets?
  • Which countries demonstrate the largest gaps in screening, early diagnosis, and disease awareness of metabolic syndrome across the 8 major markets?
  • What are the major drivers contributing to the increasing burden of metabolic syndrome across the 8 major markets?
  • How do major comorbidities and risk factors influence metabolic syndrome epidemiology trends across the 8 major markets?
  • What are the regional trends in advanced disease progression, treatment uptake, and patient management of metabolic syndrome across the 8 major markets?
  • Which patient segments represent the highest unmet clinical need in the metabolic syndrome landscape across the 8 major markets?
  • Which therapeutic areas linked to metabolic syndrome are expected to witness the strongest growth opportunities across the 8 major markets?
  • How is the metabolic syndrome epidemiology landscape expected to evolve over the next 5 to 10 years across the 8 major markets?
  • Which countries across the 8 major markets offer the most attractive market opportunities based on metabolic syndrome epidemiology and healthcare infrastructure?
  • Which epidemiological trends are expected to influence future drug development and market access strategies for metabolic syndrome across the 8 major markets?

Scope of the Metabolic Syndrome Epidemiology Report

  • The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of metabolic syndrome based on several factors.
  • Metabolic Syndrome Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
  • The metabolic syndrome report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.

Related Reports

Type 2 Diabetes Drug Pipeline

Type 2 Diabetes Mellitus Treatment Market

Hypertension Drug Pipeline

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Report Summary

Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.

Key Highlights of the Report

Please note that the figures mentioned in the description serve as estimates and may vary from the actual figures presented in the final report.

Report Features

Details

Base Year

2025

Historical Period

2019-2025

Forecast Period

2026-2035

Epidemiology Statistics Provided

  • Diagnosed Prevalent Cases
  • Type-Specific Cases
  • Gender-Specific Cases
  • Age-Specific Cases

Segmentation Provided

  • Epidemiology by Age Group
  • Epidemiology by Gender
  • Epidemiology by Type of Disease
  • Epidemiology by Region

Geographies Covered

  • United States
  • Germany
  • Italy
  • France
  • Spain
  • United Kingdom
  • Japan
  • India

Datasheet

10 % Off

USD

2,699

2,429

Single User License

10 % Off

USD

4,299

3,869

Five User License

15 % Off

USD

5,799

4,949

Corporate License

15 % Off

USD

6,999

5,949

Datasheet

One User

USD 2,699

USD 2,429

tax inclusive*

  • Selected Segments
  • Printing Restrictions
  • Excel Spreadsheet Delivered via Email
  • Full Report
  • Periodic Updates
  • Post Sales Analysts Support
  • Unlimited Prints

Single User License

One User

USD 4,299

USD 3,869

tax inclusive*

  • All Segments
  • Printing Restrictions
  • PDF Delivered via Email
  • Custom Report Layout
  • Post Sales Analysts Support
  • Periodic Updates
  • Unlimited Prints

Five User License

Five User

USD 5,799

USD 4,949

tax inclusive*

  • All Segments
  • Five Prints Available
  • PDF Delivered via Email
  • Limited Free Customization
  • Post Sales Analyst Support
  • Custom Report Layout
  • Periodic Updates
  • Unlimited Prints

Corporate License

Unlimited Users

USD 6,999

USD 5,949

tax inclusive*

  • All Segments
  • Unlimited Prints Available
  • PDF & Excel Delivery via Email
  • Limited Free Customization
  • Post Sales Analysts Support
  • Discount On Next Update
  • Custom Report Layout

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Bundle Type

Flash Bundle

20% OFF Number of Reports: 3

Small Business Bundle

25% OFF Number of Reports: 5

Growth Bundle

30% OFF Number of Reports: 8

Enterprise Bundle

35% OFF Number of Reports: 10
Overview
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 80 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 100 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Flash Bundle

Number of Reports: 3

20%

tax inclusive*

  • 3 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade
  • Free Analyst Hours

Small Business Bundle

Number of Reports: 5

25%

tax inclusive*

  • 5 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade

Growth Bundle

Number of Reports: 8

30%

tax inclusive*

  • 8 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Free Analyst Hours - 80 Hours
  • Power BI Dashboards

Enterprise Bundle

Number of Reports: 10

35%

tax inclusive*

  • 10 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Power BI Dashboards
  • Free Analyst Hours - 100 Hours

How To Order

This is a collaborative report by Vishakha Agrawal reflecting perspectives and research-driven insights from Expert Market Research.

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

License Type

Select License Type

Choose the right license for your needs and access rights.

shopping cart

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Bookmark Icon

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us